The monocular trial controversy: A critical review

Current Opinion in Ophthalmology

Volumn 20, Issue 2, 2009, Pages 104-109

  Bhorade, Anjali M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glaucoma; Monocular trial; One eyed trial; Uniocular trial; Variability of intraocular pressure

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; LATANOPROST; PROSTAGLANDIN DERIVATIVE;

ACCURACY; CIRCADIAN RHYTHM; CLINICAL TRIAL; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; EYE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; RESEARCH DESIGN;

EID: 62849102108     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283249c67     Document Type: Review

References (28)

1. Hoskins HD Jr. The management of elevated intraocular pressure with normal optic discs and visual fields. II. An approach to early therapy. Surv Ophthalmol 1977; 21:489-493.
2. Drance SM. The uniocular therapeutic trial in management of elevated IOP. Surv Ophthalmol 1980; 25:203-205.
3. Smith J, Wandel T. Rationale for the one-eye therapeutic trial. Ann Ophthalmol 1986; 18:8.
4. American Academy of Ophthalmology. Primary open-angle glaucoma, preferred practice pattern. San Francisco: American Academy of Ophthalmology; 2005. Available at: http://www.aao.org/ppp.
5. Stamper RL, Lieberman MF, Drake MV. Becker-Shaffer's diagnosis and therapy of the glaucomas. 7th Ed. St. Louis: Mosby; 1999; p. 424.
6. Chaudhary O, Adelman RA, Shields MB. Predicting response to glaucoma therapy in one eye based on response in the fellow eye: the monocular trial. Arch Ophthalmol 2008; 126:1216-1220.
7. Realini T, Fechtner RD, Atreides SP, Gollance S. The uniocular drug trial and second eye response to glaucoma medications. Ophthalmology 2004; 111:421-426.
8. Bhorade AM, Wilson BS, Palmberg P, et al., The Ocular Hypertension Treatment Study Group. The predictive accuracy of the one-eyed trial in the ocular hypertension treatment study (OHTS) [E-Abstract 5555], Invest Ophthalmol Vis Sci 2007; 48.
9. Dayanir V, Cakmak H, Berkit I. Current state of the one-eye trial of glaucoma medications: response. Clin Experiment Ophthalmol 2008; 36:136-141.
10. Takahashi M, Higashide T, Sakurai M, Sugiyama K. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects. J Glaucoma 2008; 17:169-174.
11. Rotchford AP, King AJ. Uniocular drug trials [letter]. Ophthalmology 2004; 111:2315.
12. Jones R 3rd, Triana MI, Zaslow K, Sponsel WE. Uniocular drug trial [letter]. Ophthalmology 2005; 112:1170.
13. Leffler CT, Hennessy A, Farukhi YZ. Current state of the one-eyed trial of glaucoma medications. Clin Experimental Ophthalmol 2008; 36:492-493.
14. Leffler CT, Amini L. Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series. BMC Ophthalmol 2007; 7:17.
15. Chaudhary O, Adelman RA, Shields MB, Leffler CT. Predicting response to glaucoma therapy in one eye based on response In the fellow eye: the monocular trial [letter to the editor]. Arch Ophthalmol (in press).
16. Realini T, Barber L, Burton D. Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology 2002; 109:1367-1371.
17. Bhorade AM, Gordon MO, Wilson B, et al. Ophthalmology (in press).
18. Wilensky JT, Gieser DK, Dietsche ML, et al. Individual variability in the diurnal intraocular pressure curves. Ophthalmology 1993; 100:940-944.
19. Katavisto M. The diurnal variation of ocular tension in glaucoma. Acta Ophthalmol (Suppl) 1964; 78:1-131.
20. Kitazawa Y, Horie T. Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am J Ophthalmol 1975; 79:557-567.
21. Liu JH, Sit AJ, Weinreb RN. Variation of 24-h intraocular pressure in healthy individuals: right eye versus left eye. Ophthalmology 2005; 112:1670-1675.
22. Sit AJ, Liu JH, Weinreb RN. Asymmetry of right versus left intraocular pressures over 24 h in glaucoma patients. Ophthalmology 2006; 113: 425-430.
23. Dinn RB, Zimmerman MB, Shuba LM, et al. Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma. Ophthalmology 2007; 114:915-920.
24. Shuba LM, Doan AP, Maley MK, et al. Diurnal fluctuation and concordance of intraocular pressure in glaucoma suspects and normal tension glaucoma patients. J Glaucoma 2007; 16:307-312.
25. Zimmerman TJ, Kaufman HE. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 1977; 95:601-604.
26. Piltz J, Gross R, Shin DH, et al. Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trial sin the Ocular Hypertension Treatment Study. Am J Ophthalmol 2000; 130:441-453.
27. Realini T, Vickers WR. Symmetry of fellow-eye intraocular pressure response to topical glaucoma medications. Ophthalmology 2005; 112:599-602.
28. Piltz-Seymour J, Jampel H. The One-eye drug trial revisited. Ophthalmology 2004; 111:419-420.